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REDEFINING MEDICAL NECESSITY: A 
CONSUMER-DRIVEN SOLUTION TO THE U.S. 
HEALTH CARE CRISIS 
Ryan Abbott, MD, JD, MTOM* & Carl Stevens, MD, MPH**  
          The American health care system is plagued by high costs and 
poor public health outcomes, due in part to the overuse of costly 
diagnostic tests and treatments. In 2009, the Institute of Medicine 
estimated that unnecessary care wastes $750 billion, equivalent to 
about 30 percent of health care spending. Moreover, overtreatment can 
directly harm patients as a result of surgical complications, drug 
toxicity, and hospital-acquired infections. 
          Yet while the problem of medical waste has long been recognized, 
solving the problem has proven elusive. In part, this difficulty is due to 
perverse economic incentives for physicians and hospitals, which still 
primarily receive reimbursement on a fee-for-service basis. Providers 
are financially motivated under this system to generate a higher volume 
of invasive procedures independent of their likely benefits. Patients 
generally lack the information needed to decline unnecessary services, 
even when they wish to actively share in medical decision-making, and 
a strong cultural bias pushes both patients and physicians to “do 
more,” even when evidence suggests that doing more may result in 
harm. In the 1990s, managed health care organizations attempted to 
rein in health care waste by stringently reviewing and prospectively 
denying payment for unnecessary tests and treatments, but that 
experiment was a political failure. Similarly, attempts to reduce overuse 
by shifting financial risk directly onto providers through capitated 
payment mechanisms have had limited success. The ability of these 
mechanisms to limit waste is compromised by the real or perceived 
incentive to also reduce spending on appropriate care. 
          We propose a new conception of medical necessity that will 
reduce inappropriate care by allowing informed consumers to actively 
participate in decisions about their medical care. Where evidence-
based guidelines are available, medical necessity should be determined 
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on the basis of an objective, multi-level Matrix of Appropriateness 
rather than the subjective binary decision of an insurance company’s 
medical reviewer. Such Matrices have already been created by 
systematically combining published evidence with expert judgment to 
create clinically detailed, evidence-based, multi-level medical necessity 
ratings for elective procedures based on individual patient 
characteristics. In our proposed system, if a patient desires a service 
proposed by a physician under clinical circumstances that receive low 
medical necessity ratings, the third-party payer would offer to cover the 
service but at a sliding co-payment scale imposing greater patient cost 
sharing based on the service’s appropriateness. This system would 
preserve patient choice while discouraging the overuse of costly 
treatments that provide little marginal value, reducing medical waste 
and improving the overall value of medical care. 
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Americans pay far more for their health care than citizens of 
other developed countries, while receiving less value.1 Despite a 
recent decrease in growth rate, overall expenditures in the U.S. 
health care sector approached $2.7 trillion in 2012.2 On a per capita 
basis and as a percentage of gross domestic product, the United 
States ranks first among the world’s nations in health spending by a 
substantial margin,3 yet population-level health outcome statistics 
place the United States in the middle of the pack of developing 
nations, with life expectancy ranking thirty-fourth in the World 
Health Organization’s most recent statistics, just above Barbados, 
Colombia, and Croatia.4 Assessments of health care quality in the 
United States find even more alarming results: as much as 30 percent 
of U.S. health spending represents waste, paying for services that 
offer no net health benefits to the recipient and often result in harm.5 
Medical errors and treatment complications have risen to become 
one of the nation’s leading causes of death.6 A broad range of 
interventions undertaken by public and private entities to rein in 
spending, reduce waste, improve quality and safety, and enhance 
value have yet to yield substantial gains in costs or system 
performance.7 
 
 1. Ryan Abbott, Treating the Health Care Crisis: Complementary and Alternative 
Medicine for PPACA, 14 DEPAUL J. HEALTH CARE L. 35, 36 (2011); see also Barbara Starfield, 
Commentary, Is US Health Really the Best in the World?, 284(4) JAMA 483 (2000). 
 2. CENTERS FOR MEDICARE AND MEDICAID SERVICES, NATIONAL HEALTH EXPENDITURE 
PROJECTIONS 2011–2021 available at http://www.cms.gov/Research-Statistics-Data-and-Systems 
/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/Proj2011PDF.pdf.  
 3. OECD Health Data: Economic References, OECD ILIBRARY, http://www.oecd 
-ilibrary.org/social-issues-migration-health/data/oecd-health-statistics/oecd-health-data-economic 
-references_data-00548-en;jsessionid=2hsy3us5g6883.x-oecd-live-01?isPartOf=/content 
/datacollection/health-data-en (last visited Oct. 8, 2014); see also Jason Kane, Health Costs: How 
the U.S. Compares with Other Countries, PBS NEWSHOUR THE RUNDOWN (Oct. 22, 2012, 
10:30 AM), http://www.pbs.org/newshour/rundown/2012/10/health-costs-how-the-us-compares-
with-other-countries.html. 
 4. Life Expectancy at Birth, WORLD HEALTH ORGANIZATION (2013), http://gamapserver 
.who.int/gho/interactive_charts/mbd/life_expectancy/atlas.html. 
 5. INSTITUTE OF MEDICINE OF THE NATIONAL ACADEMIES, THE HEALTHCARE 
IMPERATIVE: LOWERING COSTS AND IMPROVING OUTCOMES 74 (Pierre L. Yong et al. eds., 
2010), available at http://books.nap.edu/openbook.php?record_id=12750. 
 6. See generally LINDA T. KOHN ET AL., TO ERR IS HUMAN: BUILDING A SAFER HEALTH 
SYSTEM 26 (Nat’l Research Council ed., 2000) (stating the results of studies revealing that 
medical errors are the eighth leading cause of death in the United States). 
 7. In 2003, health care costs grew while barriers to access increased after health plans 
loosened restrictions on care in response to consumer backlash toward managed care. Cara S. 
Lesser & Paul B. Ginsburg, CTR. FOR STUDYING HEALTH SYS. CHANGE, HEALTH CARE COSTS 
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The root cause of overspending and underperformance in the 
U.S. health care system lies in our mechanisms for paying providers 
of medical services, devices, and drugs.8 The problem is twofold. 
First, we rely on free-market forces to ensure value despite 
fundamental structural features that defeat free-market functioning in 
the sector as a whole.9 Chief among these structural features that 
inhibit free-market performance is the inability of purchasers of 
health services to prospectively judge the comparative effectiveness 
of alternative treatment strategies, and to base management choices 
on these judgments.10 This limitation applies equally, regardless of 
whether the service purchaser is an individual or a third-party payer 
operating under a contractual obligation to cover the costs of all 
“necessary” treatments in exchange for premium payments.11 
Second, our payment mechanisms shield individuals from the 
financial consequences of their treatment choices, while attaching 
payment to each service rendered by providers, regardless of 
outcomes, incentivizing patients and physicians to maximize service 
utilization.12 
 
AND ACCESS PROBLEMS INTENSIFY: INITIAL FINDINGS FROM HSC’S RECENT SITE VISITS (2003), 
available at http://www.hschange.com/CONTENT/559/559.pdf; Cara S. Lesser & Paul B. 
Ginsburg, Healthcare Cost and Access Problems Intensify: Initial Findings from HSC’s Recent 
Site Visits, 63 JAMA 483 (2000). Seven years later, the United States ranked low in comparison 
to other nations in terms of health system performance despite having the most costly health 
system in the world. KAREN DAVIS ET AL., MIRROR, MIRROR ON THE WALL—HOW THE 
PERFORMANCE OF THE U.S. HEALTH CARE SYSTEM COMPARES INTERNATIONALLY 2010 
UPDATE, THE COMMONWEALTH FUND (2010), available at http://www.commonwealthfund.org 
/~/media/Files/Publications/Fund%20Report/2010/Jun/1400_Davis_Mirror_Mirror_on_the_wall_
2010.pdf. And in 2013, high costs and poor system performance of the health care system remain 
serious issues in the United States. See generally CATHY SCHOEN ET AL., THE COMMONWEALTH 
FUND, CONFRONTING COSTS—STABILIZING U.S. HEALTH SPENDING WHILE MOVING TOWARD 
A HIGH PERFORMANCE HEALTH CARE SYSTEM (2013), available at http:// 
www.commonwealthfund.org/~/media/Files/Publications/Fund%20Report/2013/Jan/1653_Comm
ission_confronting_costs_web_FINAL.pdf. 
 8. See generally THE COMMONWEALTH FUND, THE PATH TO A HIGH PERFORMANCE U.S. 
HEALTH SYSTEM: A 2020 VISION AND THE POLICIES TO PAVE THE WAY (2009), available at 
http://www.commonwealthfund.org/~/media/Files/Publications/Fund%20Report/2009/Feb/The 
%20Path%20to%20a%20High%20Performance%20US%20Health%20System/1237_Commissio
n_path_high_perform_US_hlt_sys_WEB_rev_03052009.pdf (discussing the need to change the 
way the United States delivers and pays for health care to reduce health care costs and increase 
access). 
 9. See Paul Krugman, Op-Ed., Why Markets Can’t Cure Healthcare, N.Y. TIMES  
(July 25, 2009, 5:07 PM), http://krugman.blogs.nytimes.com/2009/07/25/why-markets-cant-cure 
-healthcare/. 
 10. See id. 
 11. See id. 
 12. See, e.g., Toby Gosden et al., Capitation, Salary, Fee-for-Service and Mixed Systems of 
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In contrast to most other economically advanced nations whose 
citizens have elected to include medical care within a package of 
social benefits defined by national statutes,13 U.S. citizens receive 
medical goods and services through a complex web of legal contracts 
between individuals and a broad array of public and private 
entities.14 In the most common model, firms contract with 
commercial third-party health insurance entities to pay for health 
services, devices, and pharmaceuticals needed by their employees.15 
For citizens older than sixty-five, the federally funded Medicare 
program effectively contracts with individual hospitals, physicians, 
and pharmacies to pay for professional services, facility costs, and 
prescription medicines.16 A hybrid arrangement in which Medicare 
purchases private health insurance on behalf of members represents a 
smaller segment of the over sixty-five market, and creates 
contractual relationships between Medicare members and third-party 
health plans that mirror employee benefit coverage.17 
All of the contractual relationships between health care 
 
Payment: Effects on the Behaviour of Primary Care Physicians (Review), 3 COCHRANE 
DATABASE OF SYSTEMATIC REVIEW (2000), available at onlinelibrary.wiley.com/doi 
/10.1002/14651858.CD002215/pdf (evidencing that a fee-for-service payment system resulted in 
primary care physicians providing, and patients using, a higher quantity of care). In addition to 
direct financial incentives, providers are also motivated to provide medically unnecessary 
services for defensive medical purposes. See, e.g., Daniel Kessler & Mark McClellan, Do Doctors 
Practice Defensive Medicine, 111 Q. J. OF ECON. 353, 388 (1996). For example, an emergency 
room physician may order a head computerized tomography (CT) scan on a patient who reports 
head trauma, even in the absence of a clear medical indication. This may be because the physician 
is concerned about malpractice liability, and there is little downside to the physician for ordering 
the imaging. However, a CT scan and analysis by a radiologist represents a substantial medical 
expense, and the test also exposes the patient to unnecessary radiation. Choosing Wisely: Imaging 
Tests For Lower-Back Pain, CONSUMER REPORTS (2012), http://consumerhealthchoices.org/wp-
content/uploads/2012/06/ChooseWiselyBackPainAAFP-ER.pdf. Similarly, doctors may order 
imaging to satisfy patients. If a patient with lower back pain desires an MRI in the absence of a 
clear medical indication, there is again little downside to the physician for ordering such a test 
and making the patient happy. Cultural norms also promote “doing more,” even when there is 
evidence that doing more may be harmful. See generally OTIS WEBB BRAWLEY, HOW WE DO 
HARM: A DOCTOR BREAKS RANKS ABOUT BEING SICK IN AMERICA (2011) (providing real-life 
examples of various scenarios where additional procedures may harm patients). 
 13. Max Fisher, Here’s a Map of the Countries That Provide Universal Health Care 
(America’s Still Not in It), THE ATLANTIC (June 28, 2012, 6:09 PM), http://www.theatlantic.com 
/international/archive/2012/06/heres-a-map-of-the-countries-that-provide-universal-health-care 
-americas-still-not-on-it/259153/. 
 14. William Sage, Managed Care’s Crimea: Therapeutic Benefit, and the Goals of 
Administrative Process in Health Insurance, 53 DUKE L.J. 597, 609–12 (2003). 
 15. See id. 
 16. Robert B. Friedland, How Medicare Works, 29 GENERATIONS 1, 30 (2005). 
 17. Id. 
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purchaser and third-party plans, as well as those between the plans 
and their individual beneficiaries, revolve around the crucially 
important but loosely defined concept of “medical necessity.”18 
Medical necessity is a term of art in the health insurance industry that 
may be used to determine whether insurance will cover an 
intervention for an individual patient.19 All purchasers of health 
benefits, including federal and state governments, Employee 
Retirement Income Security Act (ERISA) covered health plans, 
smaller firms that purchase health benefits for employees in the 
commercial insurance market, and the small minority of citizens who 
purchase individual policies from private health plans, enter into 
contracts that legally entitle each member to all medically necessary 
services.20 Since working definitions of medical necessity remain 
vague, typically referring to generally accepted practice standards or 
to services deemed necessary by a qualified physician or other health 
care provider, risk-bearing payers face essentially unlimited exposure 
to utilization and costs, which are largely at the discretion of 
providers reimbursed on a fee-for-service basis that incentivizes 
maximal utilization of all types of health services.21  
Existing contracts deploy medical necessity as a binary or 
dichotomous variable: for any given patient under a particular 
clinical circumstance, each service is either “medically necessary” or 
unnecessary, without any acknowledged middle ground to reflect 
variability and uncertainty in the expected benefits, costs and harms 
 
 18. See generally Mark A. Hall & Gerard F. Anderson, Health Insurers’ Assessment of 
Medical Necessity, 140 U. PA. L. REV. 1637, 1637–51 (1992) (discussing insurers’ use of medical 
necessity in determining payment for health care services). 
 19. See id. at 1663–65 (describing a trend among insurers, since the mid-1970s, to control 
costs by scrutinizing medical necessity). 
 20. 15 AM. JUR. 3D Proof of Facts § 355 (1992). 
 21.  
[T]he excess baggage of “medical necessity” is not its pejorative connotation, but 
rather its multiplicity of meanings. In today’s health care system, parties with a range 
of backgrounds and biases are involved in medical necessity decisions. To many 
physicians, the phrase “not medically necessary” means “not clinically indicated,” 
which makes them question why a seemingly nonprofessional party such as a health 
plan has the right to challenge their professional opinion. To many health plans, it 
means “not covered even though not expressly excluded from coverage,” which gives 
them a degree of comfort issuing denials based on established insurance practice even 
though such decisions outrage physicians. Consequently, decisions involving medical 
necessity are frequently characterized by inconsistent administration, poor 
communication, distrust and, if disputes arise, relatively unprincipled, results-oriented 
judicial resolution.  
Sage, supra note 14, at 601. 
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of diagnostic tests or treatments.22 Indeed, providers function under a 
de facto presumption of medical necessity for the services they 
render to patients, only rarely facing challenges on the need for 
services either before or after they were rendered.23 During the 
1990s, payer organizations tried to control costs by engaging in 
detailed prospective case review and mandatory precertification for 
elective surgical and diagnostic procedures.24 This brief experiment 
failed following a political backlash from both consumers and 
providers contending undue interference by financially motivated 
third parties in the doctor-patient relationship.25 With few exceptions, 
payers have now retreated from attempts to second-guess front-line 
providers on the medical necessity of procedures they perform, 
unleashing yet another round of steady increases in the volume of 
complex imaging procedures, elective surgeries, and overall health 
care costs.26 
Viewed from a clinical perspective, the insurance industry’s 
construction of medical necessity as a dichotomous variable bears 
little resemblance to the realities of medical decision-making and 
practice. Although financially it stacks the deck dramatically in favor 
of providers, who can justify nearly any intervention under the 
tautological principle that any procedure frequently performed by 
licensed physicians is medically necessary because it represents 
“standard practice.”27 In clinical settings, the medical necessity or 
appropriateness of any given test or treatment for a particular patient 
 
 22. See, e.g., Medically Necessary/Medical Necessity, HEALTHPARTNERS (2013), http:// 
www.healthpartners.com/public/coverage-criteria/medically-necessary; Shield Savings and 
Spectrum PPO Savings Plan, BLUE SHIELD OF CALIFORNIA LIFE AND HEALTH INSURANCE 
COMPANY (2013), https://www.blueshieldca.com/producer/documentlibrary/A16490-8_7-9.pdf 
(discussing plan coverage of services that are deemed medically necessary). 
 23. Timothy P. Blanchard, “Medical Necessity” Determinations—A Continuing Healthcare 
Policy Problem, 37 J. HEALTH L. 599, 618–19 (2004). 
 24. James C. Robinson, The End of Managed Care, 285 JAMA, 2622, 2622–23 (2001). 
 25. Id. 
 26. Id. 
 27. Furthermore, additional deference may be given to the opinion of a treating physician, as 
the party presumably most familiar with an individual patient’s clinical needs. “The ‘treating 
physician rule’, as adopted by some courts, dictates that the treating physician’s determination 
that a service is medically necessary is binding unless contradicted by substantial evidence, and is 
entitled to some extra weight, even if contradicted by substantial evidence, because the treating 
physician is inherently more familiar with the patient’s medical condition.” Andrew B. Wachler, 
The New Audit Landscape: MICs, MACs, and RACs (Medicaid Integrity Contractors, Medicare 
Administrative Contractors, and Recovery Audit Contractors), AMERICAN HEALTH LAWYERS 
ASSOCIATION, http://www.healthlawyers.org/Events/Programs/Materials/Documents/HHs10 
/wachler.pdf (citations omitted) (last visited Feb. 20, 2014). 
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depends on a complex set of clinical circumstances, and rarely 
reflects a simple dichotomous or binary judgment.28 Instead, 
depending in part on individual patient circumstances, any given 
intervention falls somewhere between the following categories: 
(a) unequivocally necessary; (b) desirable on balance but not entirely 
necessary; (c) unnecessary because expected benefits to the patient 
do not justify the costs, time, or risk; or (d) unnecessary and 
contraindicated due to the greater likelihood of net harm to the 
patient. While these determinations are made routinely by practicing 
clinicians based on their training, personal experience, and implicit 
judgment, a well-developed scientific approach also exists for the 
quantitative assessment of medical necessity. Thus, a more nuanced 
approach to judging the need for procedures is feasible, and the 
requisite methodology has been broadly applied and described in 
detail in the peer-reviewed medical literature. 
Beginning in the early 1980s, Robert Brook led a group of 
health services researchers at RAND in an ambitious scientific 
initiative to quantitatively determine the medical necessity of 
commonly performed elective diagnostic and therapeutic 
procedures.29 These researchers used explicit methods that combined 
published evidence from the peer-reviewed medical literature with 
 
 28. Marc A. Koopmanschap et. al., Dear Policy Maker: Have You Made Up Your Mind? A 
Discrete Choice Experiment Among Policy Makers and Other Health Professionals, 26:2 INT’L J. 
TECH. ASSESSMENT IN HEALTH CARE 198, 203–04 (2010); see also, Linda A. Bergthold, Medical 
Necessity: Do We Need It? 14 HEALTH AFFAIRS, 180–81 (1998) (tracing the history and use of 
the term “medical necessity”). 
 29. The RAND/UCLA Appropriateness Method (RAM) is “only one of several methods that 
have been developed to identify the collective opinion of experts.” KATHRYN FITCH ET AL., THE 
RAND/UCLA APPROPRIATENESS METHOD USER’S MANUAL (2001), http://www.rand.org 
/content/dam/rand/pubs/monograph_reports/2011/MR1269.pdf. The RAM  
was developed in the mid-1980s, as part of the RAND Corporation/University of 
California Los Angeles (UCLA) Health Services Utilization Study, primarily as an 
instrument to enable the measurement of the overuse and underuse of medical and 
surgical procedures. In the RAM, the concept of appropriateness refers to the relative 
weight of the benefits and harms of a medical or surgical intervention. An appropriate 
procedure is one in which ‘the expected health benefit (e.g., increased life expectancy, 
relief of pain, reduction in anxiety, improved functional capacity) exceeds the expected 
negative consequences (e.g., mortality, morbidity, anxiety, pain, time lost from work) 
by a sufficiently wide margin that the procedure is worth doing, exclusive of cost[.]’ 
Robert H. Brook, who identified the need for a tool to measure the appropriateness of 
care, explained that ‘it was motivated by the concern that the increasing complexity of 
medical care was resulting in some patients not undergoing procedures that they 
needed, and others undergoing procedures that they did not need[.]’  
Id. at 1 (internal quotation marks and citations omitted). 
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the balanced judgment of multi-disciplinary expert clinician panels in 
a nominal group process that limited the impact of any individual 
panel member on final results.30 Using a multi-round modified 
Delphi method,31 panelists rated the medical necessity of each 
procedure in hundreds of individual, detailed clinical scenarios using 
a nine-point Likert scale.32 A rating of one on the Likert scale 
indicated a clinical circumstance in which the procedure was deemed 
both unnecessary and inappropriate, a five reflected an equivocal 
rating, and a nine anchored the upper end of the scale, denoting a 
clinical scenario in which panelists deemed the intervention in 
question to be both appropriate and necessary.33 Of note, panelists 
were explicitly instructed to ignore monetary costs in their judgments 
of medical necessity and adhere to a strict definition deeming a 
procedure necessary to the extent that its expected medical benefits 
sufficiently exceeded the likely medical risks to make the procedure 
worthwhile.34 These methods developed at RAND were later adopted 
by other academic institutions, private firms, and publicly funded 
delivery systems in Europe to more precisely assess the necessity of 
specific procedures based on detailed clinical scenarios.35  
The quantitative construction of medical necessity combining 
published evidence with expert consensus invented at RAND holds 
that medical necessity represents a multi-level, ordinal variable, 
anchored on the high end by life-saving procedures such as 
appendectomy for acute appendicitis or immediate surgery to control 
hemorrhage resulting from trauma, and on the low end by any 
 
 30. Id. 
 31. The “Delphi method” was developed at RAND in the 1950s as a tool to predict the 
future, and it has come to be used in a variety of health and medical settings. “The method 
generally involves multiple rounds, in which a questionnaire is sent to a group of experts who 
answer the questions anonymously. The results of the survey are then tabulated and reported back 
to the group, and each person is asked to answer the questionnaire again. This iterative process 
continues until there is a convergence of opinion on the subject or no further substantial changes 
in the replies are elicited.” Id. 
 32. “A Likert scale is an ordered scale from which respondents choose one option that best 
aligns with their view. It is often used to measure respondents’ attitudes by asking the extent to 
which they agree or disagree with a particular question or statement. A typical scale might be 
‘Strongly disagree, Disagree, Neutral, Agree, Strongly agree.’” Jan Losby & Anne Wemore, CDC 
Coffee Break: Using Likert Scales in Evaluation Survey Work, NAT’L CENTER FOR CHRONIC 
DISEASE PREVENTION AND HEALTH PROMOTION (2013), http://www.cdc.gov/dhdsp/pubs/docs 
/CB_February_14_2012.pdf. 
 33. Fitch, supra note 29.  
 34. Id. at 4. 
 35. See generally id. 
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procedures whose medical risks outweigh their benefits, including 
entirely elective surgical interventions for cosmetic or lifestyle 
enhancement.36 Between these two extremes, the RAND method 
recognizes intermediate levels of necessity that balance the likely 
benefits of a procedure against its possible harms, as well as the 
comparative benefits of alternative, less invasive interventions.37 
While methodologically demanding to produce and deploy, this 
multi-level conception of medical necessity reflects much more 
closely the approach applied daily by practicing physicians than does 
the dichotomous model enshrined in existing contracts between 
payers and health plans on the one hand, and between health plans 
and their members on the other. Some examples will help illustrate 
how this more nuanced conception of medical necessity works in 
practice.38 The RAND method was applied to hysterectomy, the 
surgical removal of the uterus (and often the ovaries), a common 
procedure performed for a variety of indications and complaints.39 
The expert panels charged with determining the clinical 
circumstances under which hysterectomy is medically necessary 
focused their attention on indications where the surgery might yield 
symptomatic improvement, but also entails significant risks and 
represents one of a range of alternative treatment options (such as 
medical management or less invasive surgical interventions).40 The 
panel deemed hysterectomy performed to treat gynecologic cancer to 
be unequivocally necessary and was not included in this study.41 
 
 36. See generally id. 
 37. Id. at 2. 
 38.  
Many procedures have been the subject of appropriateness studies in the United States, 
among them, coronary angiography, coronary artery bypass graft surgery, percutaneous 
transluminal coronary angioplasty, carotid endarterectomy, abdominal aortic aneurysm 
surgery, diagnostic upper gastrointestinal endoscopy, cataract surgery, colonoscopy, 
cholecystectomy, hysterectomy, tympanostomy and spinal manipulation for lower back 
pain. The method has since been applied to some of these as well as other conditions 
and procedures—benign prostatic hyperplasia, laminectomy, breast cancer and total 
hip replacement—in a wide variety of countries, including Canada, Israel, Italy, The 
Netherlands, Spain, Sweden, Switzerland, and the United Kingdom. Use continues to 
expand to other countries, particularly in Western Europe.  
Id. at 2 (internal citations omitted). 
 39. Michael S. Broder, et al., The Appropriateness of Recommendations for Hysterectomy, 
95 OBSTET GYNECOL 199, 199–205 (2000), http://media.redding.com/media/static/The 
_Appropriateness_of_Recommendations_for.7.pdf. 
 40. Id. at 200. 
 41. Id. at 202. 
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Instead, the experts focused their attention on the most common 
indications for elective hysterectomy such as abnormal uterine 
bleeding and pelvic pain.42 For these indications, the panelists rated 
the medical necessity on the nine-point scale, based on balancing the 
expected benefits against the likely risks of surgery, as well as the 
availability of effective nonsurgical alternatives.43 
For example, a forty-two-year-old woman proposed for a 
hysterectomy to control abnormal uterine bleeding, who had not 
received a trial of hormonal treatment or more limited surgeries such 
as dilation and curettage44 and whose daily functioning was not 
dramatically impacted by her bleeding symptoms, received low 
medical necessity ratings in the one to three range, because of the 
availability of less invasive alternative treatments that often yield 
acceptable outcomes in these circumstances.45 In contrast, if the 
same patient had failed the trial of hormonal treatment, did not 
respond to less invasive procedures, and was frequently limited in 
her daily activities due to bleeding or required multiple transfusions 
to replace blood loss, hysterectomy received high necessity ratings in 
the seven to nine range.46 In other words, by combining evidence 
from published outcomes studies with multidisciplinary expert 
opinion, the RAND researchers were able to define a range of 
necessity for a common procedure based on the detailed clinical 
circumstances under which it was undertaken.47 
To illustrate, an excerpt of the Matrix48 for evaluating 
hysterectomy (here only in a subset of patients with cervical 
dysplasia) is listed, along with an interpretation guide.49 
 
 
 
 42. Id. at 200–03. 
 43. Id. at 200. 
 44. Dilation and Curettage: Frequently Asked Questions, THE AM. C. OF OBSTETRICIANS 
AND GYNECOLOGISTS (2012), http://www.acog.org/~/media/For%20Patients/faq062.pdf?dmc 
=1&ts=20131219T0414505549. “D&C [dilation and curettage] is a surgical procedure in which 
the cervix is opened (dilated) and a thin instrument is inserted into the uterus. This instrument is 
used to remove tissue from the inside of the uterus (curettage) . . . D&C is used to diagnose and 
treat many conditions that affect the uterus, such as abnormal bleeding.” Id.  
 45. Broder et al., supra note 39, at 202. 
 46. Id. 
 47. Id. at 201–03. 
 48. STEVEN J. BERNSTEIN, RAND, S. CAL. HEALTH RESEARCH CONSORTIUM, 
HYSTERECTOMY RATINGS OF APPROPRIATENESS 9 (1997). 
 49. Id. at 12. 
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Hysterectomy is Indicated In Patients with 
Cervical Dysplasia Who State They: 
Degree of Dysplasia 
CIN I or II 
Degree of 
Dysplasia 
CIN III/CIS 
PREFER UTERINE PRESERVATION 
9
1 2 3 4 5 7 8 9 
  (1.0, 0.0, A) 
9
1 2 3 4 5 7 8 9 
  (1.0, 0.0, A) 
DO NOT PREFER UTERINE PRESERVATION, ARE <40 
YEARS OLD AND HAVE: 
   
No prior conization or excision:
No Children    
9
1 2 3 4 5 6 7 8 9 
  (1.0, 0.0, A) 
8    1
1 2 3 4 5 6 7 8 9 
  (1.0, 0.2, A) 
Children 
9
1 2 3 4 5 6 7 8 9 
  (1.0, 0.0, A) 
6 2 1
1 2 3 4 5 6 7 8 9 
  (1.0, 0.4, A) 
One prior conization or exision performed with 
clear margins of resection:  
   
No Recurrence 
No Children 
9
1 2 3 4 5 6 7 8 9 
  (1.0, 0.0, A) 
8 1
1 2 3 4 5 6 7 8 9 
  (1.0, 0.1, A) 
Children 
9
1 2 3 4 5 6 7 8 9 
  (1.0, 0.0, A) 
7 2
1 2 3 4 5 6 7 8 9 
  (1.0, 0.2, A) 
Recurrence 2 or more years after conservative 
procedure 
   
No Children 
5 3
1 2 3 4 5 6 7 8 9 
  (1.0, 0.4, A) 
2 3 1 1          1 
1 2 3 4 5 6 7 8 9 
  (2.0, 1.4, A) 
Children 
6 3
1 2 3 4 5 6 7 8 9 
  (1.0, 0.3, A) 
2 2 2 2          1   
1 2 3 4 5 6 7 8 9 
  (3.0, 1.4, I) 
Recurrence < 2 years after conservative 
procedure 
   
No Children 
4 3 1 1
1 2 3 4 5 6 7 8 9 
  (2.0, 0.8, A) 
1 3 3          1 1 
1 2 3 4 5 6 7 8 9 
  (3.0, 1.6, A) 
Children 
4 3 1 1
1 2 3 4 5 6 7 8 9 
  (2.0, 0.8, A) 
1 1 4 1       1 1 
1 2 3 4 5 6 7 8 9 
  (3.0, 1.4, I) 
One prior conization or excision performed with 
margins of resection showing dysplasia 
   
No repeat sampling or no dysplasia on repeat 
sampling 
   
No Children 
8 1          
1 2 3 4 5 6 7 8 9 
  (1.0, 0.1, A) 
8 1           
1 2 3 4 5 6 7 8 9 
  (1.0, 0.1, A) 
Children 
8 1          
1 2 3 4 5 6 7 8 9 
  (1.0, 0.1, A) 
8    1       
1 2 3 4 5 6 7 8 9 
  (1.0, 0.2, A) 
Repeat sampling shows dysplasia
No Children 
4 3 2          
1 2 3 4 5 6 7 8 9 
  (2.0, 0.7, A) 
1 1 4 2          1 
1 2 3 4 5 6 7 8 9 
  (3.0, 1.1, I) 
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Children  3 3 3          
1 2 3 4 5 6 7 8 9 
  (2.0, 0.7, A) 
1 1 3 2 1       1 
1 2 3 4 5 6 7 8 9 
  (3.0, 1.3, I) 
Two or more prior conizations or excisions 
performed with clear margins of resection on 
last procedure 
   
No recurrence 
No Children 
8 1          
1 2 3 4 5 6 7 8 9 
  (1.0, 0.1, A) 
7 2           
1 2 3 4 5 6 7 8 9 
  (1.0, 0.2, A) 
Children 
9          
1 2 3 4 5 6 7 8 9 
  (1.0, 0.0, A) 
8 1           
1 2 3 4 5 6 7 8 9 
  (1.0, 0.1, A) 
Recurrence 2 or more years after conservative 
procedure 
   
No Children 
4 3 2          
1 2 3 4 5 6 7 8 9 
  (2.0, 0.7, A) 
     3 2 1    1 1 1 
1 2 3 4 5 6 7 8 9 
  (4.0, 1.8, D) 
Children 
3 3 3        
1 2 3 4 5 6 7 8 9 
  (2.0, 0.7, A) 
     1 3 2    1    2 
1 2 3 4 5 6 7 8 9 
  (5.0, 1.6, I) 
Recurrence < 2 years after conservative 
procedure 
   
No Children 
3 2 3 1       
1 2 3 4 5 6 7 8 9 
  (2.0, 0.9, A) 
     1 3 2    1    2 
1 2 3 4 5 6 7 8 9 
  (5.0, 1.7, I) 
Children 
2 3 3 1          
1 2 3 4 5 6 7 8 9 
  (2.0, 0.9, A) 
     1 3 1 1 1    2         
1 2 3 4 5 6 7 8 9 
  (5.0, 1.8, I) 
More than one prior conization or excision with 
margins of resection showing dysplasia 
   
No repeat sampling or no dysplasia on repeat 
sampling 
   
No Children 
6 2 1          
1 2 3 4 5 6 7 8 9 
  (1.0, 0.4, A) 
4 2 2             1           
1 2 3 4 5 6 7 8 9 
  (2.0, 1.3, A) 
Children 
6 2 1          
1 2 3 4 5 6 7 8 9 
  (1.0, 0.4, A) 
4 1 3             1          
1 2 3 4 5 6 7 8 9 
  (2.0, 1.4, A) 
Repeat sampling shows dysplasia
No Children 
3 3 1 2          
1 2 3 4 5 6 7 8 9 
  (2.0, 0.9, A) 
1 1    1 1 1 1 1 2         
1 2 3 4 5 6 7 8 9 
  (6.0, 2.3, I) 
Children 
3 3 2 1          
1 2 3 4 5 6 7 8 9 
  (2.0, 0.8, A) 
1 1    1 2    1 1 2         
1 2 3 4 5 6 7 8 9 
  (5.0, 2.3, I) 
DO NOT PREFER UTERINE PRESERVATION, ARE 40 
YEARS OR OLDER, AND HAVE: 
   
 
 
 
No prior conization or excision 
 
9 
1 2 3 4 5 6 7 8 9 
  (1.0, 0.0, A) 
 
7 1       1 
1 2 3 4 5 6 7 8 9 
  (1.0, 0.6, A) 
One prior conization or excision performed with 
clear margins of resection 
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No recurrence 
9
1 2 3 4 5 6 7 8 9 
  (1.0, 0.0, A) 
9
1 2 3 4 5 6 7 8 9 
  (1.0, 0.0, A) 
Recurrence 2 or more years after conservative 
procedure 
5 4
1 2 3 4 5 6 7 8 9 
  (1.0, 0.4, A) 
2 1 5                1 
1 2 3 4 5 6 7 8 9 
  (3.0, 1.2, A) 
Recurrence < 2 years after conservative 
procedure 
4 2 3
1 2 3 4 5 6 7 8 9 
  (2.0, 0.8, A) 
1 1 3 1 1    1    1 
1 2 3 4 5 6 7 8 9 
  (3.0, 1.8, I) 
One Prior conization or excision performed with 
margins of resection showing dysplasia 
   
No repeat sampling or no dysplasia on repeat 
sampling 
8 1
1 2 3 4 5 6 7 8 9 
  (1.0, 0.1, A) 
8    1
1 2 3 4 5 6 7 8 9 
  (1.0, 0.2, A) 
Repeat sampling shows dysplasia 
3 2 4
1 2 3 4 5 6 7 8 9 
  (2.0, 0.8, A) 
1 1 1 2 2 1       1 
1 2 3 4 5 6 7 8 9 
  (4.0, 1.7, I) 
Two or more prior conizations or excisions 
performed with clear margins of resection on 
last procedure 
   
No recurrence 
8 1
1 2 3 4 5 6 7 8 9 
  (1.0, 0.1, A) 
8       1
1 2 3 4 5 6 7 8 9 
  (1.0, 0.3, A) 
Recurrence 2 or more years after conservative 
procedure 
4    5
1 2 3 4 5 6 7 8 9 
  (3.0, 0.9, A) 
1    2 1 1 1 1 1 1 
1 2 3 4 5 6 7 8 9 
  (5.0, 2.1, D) 
Recurrence < 2 years after conservative 
procedure 
3 1 4    1
1 2 3 4 5 6 7 8 9 
  (3.0, 1.0, A) 
     2 2 1 1    2 1 
1 2 3 4 5 6 7 8 9 
  (5.0, 1.9, I) 
More than one prior conization or excision with 
margins of resection showing dysplasia 
   
No repeat sampling or no dysplasia on repeat 
sampling 
7    2
1 2 3 4 5 6 7 8 9 
  (1.0, 0.4, A) 
6    1    2 
1 2 3 4 5 6 7 8 9 
  (1.0, 1.1, A) 
Repeat sampling shows dysplasia 
3 1 3 1 1
1 2 3 4 5 6 7 8 9 
  (3.0, 1.1, A) 
1       2 1 2     2 1 
1 2 3 4 5 6 7 8 9 
  (6.0, 1.9, I) 
 
 
The use of advanced imaging in the setting of low back pain 
offers another example of the same principle. Acute low back pain 
represents one of the most common indications for patients to seek 
medical care in the United States.50 The vast majority of these 
episodes resolve within a few days to weeks without specific 
treatment beyond short-term symptom control with appropriate 
analgesics.51 Some of these episodes result from specific anatomic 
 
 50. See Steven J. Atlas & Richard A. Deyo, Evaluating and Managing Acute Low Back Pain 
in the Primary Care Setting, 16 J. GEN. INTERNAL MED. 120, 120 (2001) available at 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1495170/pdf/jgi_91141.pdf.  
 51. Barbara S. Webster et al., Iatrogenic Consequences of Early Magnetic Resonance 
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derangements such as lumbar disc herniation, but even these 
episodes resolve without surgical intervention in approximately 60 to 
70 percent of cases.52 Despite this, patients presenting with low back 
pain often receive advanced imaging, such as magnetic resonance 
imaging (MRI), early in the course of their illness. 
These imaging tests may reveal abnormalities, such as disc 
herniations, that arouse concern for both patient and practitioner 
despite the well-documented fact that herniated disc symptoms, 
while initially severe, generally improve rapidly with non-operative 
measures and most often resolve spontaneously in the course of a 
few weeks.53 The presence of the radiographic abnormality, in 
combination with severe symptoms, often leads to unnecessary lower 
back surgery.54 Applying the RAND approach, a patient with acute 
low back pain, even with features strongly suggestive of lumbar disc 
herniation, such as radiation of pain to the lower extremity, would 
receive a low rating of medical necessity for MRI early in the course 
of the illness in the absence of signs of serious neurologic 
compromise.55 However, following a trial of conservative treatment, 
which might include physical therapy and other non-operative 
treatments, if this same patient remained limited by back and leg pain 
after several weeks then imaging could be used to determine the 
likely benefit from disc surgery. This would move the determination 
of medical necessity toward the high end of the scale, since the 
failure of symptoms to resolve with non-operative measures on 
balance favors surgical intervention for patients who desire more 
rapid relief of symptoms.56 Moving from a binary or dichotomous 
definition of medical necessity to a more nuanced, multi-level rating 
based on detailed clinical circumstances offers a number of 
intriguing possibilities for reducing unnecessary care and controlling 
 
Imaging in Acute, Work-Related, Disabling Low Back Pain, 32 SPINE 1939 (2013) (“Early MRI 
without indication has a strong iatrogenic effect in acute LBP, regardless of radiculopathy status. 
Providers and patients should be made aware that when early MRI is not indicated, it provides no 
benefits, and worse outcomes are likely.”). 
 52. Alessandra Splendiani et. al., Spontaneous Resolution of Lumbar Disk Herniation: 
Predictive Signs for Prognostic Evaluation, 46 NEURORADIOLOGY 916, 919 (2004). 
 53. Id. 
 54. Derek J. Emery et al., Overuse of Magnetic Resonance Imaging, 173 JAMA INTERNAL 
MED. 823, 824 (2013) (finding “evidence of substantial overuse of lumbar spine MRI scans” 
where “[o]ver half the requests (55.7%) were inappropriate (28.5%) or of uncertain value 
(27.2%)”). 
 55. See id. at 823–24. 
 56. Id. 
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costs.57 At the same time, this multi-level rating system can improve 
value from both the patient’s and the payer’s perspectives.58 
Validated multi-level ratings of medical necessity, based on clinical 
circumstances for a majority of commonly performed and costly 
diagnostic and therapeutic procedures, could be deployed in a variety 
of ways to ensure that patients who stand to substantially benefit 
retain access to these procedures59 while those who might benefit 
more from alternative and less complex interventions are offered 
both an opportunity and an incentive to select them. Here, we 
explore only one possible application of multi-level medical 
necessity: varying the patient’s co-payment for the procedure based 
on experts’ ratings of medical necessity under specific, detailed 
clinical circumstances. 
In the examples offered above, a woman desiring a 
hysterectomy for bleeding prior to a trial of conservative treatment 
would not be denied coverage based on a failure to meet a medical 
necessity threshold. Instead, she might be offered the procedure with 
a 30 to 40 percent co-pay prior to undergoing the surgery, perhaps 
amounting to several thousand dollars. However, the same patient, 
after failing an adequate trial of alternative non-operative treatments, 
might receive the surgery with a low or even no co-pay since the 
failure of alternative therapy increases the appropriateness of a 
surgical intervention. In the low back pain example, a patient 
desiring an MRI during the first week of his symptoms could be 
offered the procedure with a 50 percent co-pay. Alternatively, should 
he elect to delay the imaging and try non-operative treatments, but 
remain symptomatic and disabled by his back and leg symptoms 
after a period of six to eight weeks, he would receive imaging with a 
nominal or no co-pay since the failure of symptoms to follow the 
usual pattern of spontaneous resolution places the patient in a 
different clinical category where the benefits of imaging and 
decompressive surgery of a disc herniation begin to outweigh the 
potential risks. 
 
 57. Anthony J. Culyer & Yvonne Bombard, An Equity Framework for Health Technology 
Assessments, 32 MED. DECISION MAKING 428, 429 (2012) (“The framework is primarily intended 
for high-level decision makers who specify the criteria to be used by HTA advisory 
committees.”); see Sara Rosenbaum et al., Who Should Determine When Health Care Is 
Medically Necessary?, 340 NEW ENG. J. MED. 229, 230 (1999). 
 58. Culyer & Bombard, supra note 57, at 429.  
 59. Id. at 429–31. 
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Varying the co-payment to reflect the level of medical necessity 
determined by published evidence and expert opinion has several 
advantages. This variation retains an element of patient choice in 
accessing complex or invasive treatments, while incentivizing 
patients to try less invasive and costly alternatives in circumstances 
where these treatments are likely to result in similar outcomes. 
Properly executed by an impartial body, detailed medical necessity 
criteria could serve as the basis for overcoming a principal cause of 
market failure in the health care sector, namely the inability of the 
typical consumer to judge on his or her own the relative merits of 
different diagnostic and treatment approaches. It would provide 
patients, as well as payers and providers, with expert input on the 
comparative effectiveness of different treatment strategies.60 In 
comparison to outright denials of service based on adverse medical 
necessity decisions attempted by health plans during the 1990s, 
which resulted in a public opinion backlash that scuttled the first 
round of managed care reforms,61 the variable co-payment approach 
may more closely reflect societal values favoring freedom of choice 
among treatment options by individuals and their physicians,62 while 
at the same time giving consumers access to evidence-based 
guidance on the relative costs and advantages of the different 
treatments available to them. 
However, the variable co-pay approach proposed here has 
several important limitations. Chief among these limitations is the 
challenge of developing multi-level medical necessity ratings for 
common or costly treatments based on an unbiased and broadly 
representative interpretation of existing published data on the 
comparative effectiveness of different treatments, using validated 
methods to combine expert opinion with published evidence. The 
RAND approach offers one example of how this can be 
accomplished,63 and advances in information technology allowing 
broader input from a larger, geographically dispersed panel of 
experts would further enhance adaptation of these proven methods to 
current circumstances.64 Strict avoidance of any conflict of interest 
 
 60. See sources cited supra note 57. 
 61. See Sage, supra note 14, at 609–12. 
 62. RJ Belndon et al., Understanding the Managed Care Backlash, 17 HEALTH AFF., 80, 81 
(1998). 
 63. See supra notes 27–34. 
 64. Referring to the importance of a varied panel of experts, the article states that “[t]he 
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between those involved in developing medical necessity ratings and 
entities applying them in variable co-payment contracts would be 
critical to the ethical and sustainable implementation of this 
approach.  
Independent, non-profit organizations such as the Patient-
Centered Outcomes Research Institute (PCORI) and the Institute of 
Medicine (IOM) may be the most appropriate parties to generate 
Matrices of Appropriateness.65 While health insurance companies 
could internally develop Matrices, their financial incentives to limit 
spending on necessary as well as unnecessary care,66 and the public 
perception that insurers do not always act in the best interests of their 
enrollees,67 may limit the effectiveness of insurer-developed 
Matrices. Alternately, a government agency, such as the Centers for 
Medicare and Medicaid Services (CMS), might develop Matrices for 
internal use or to disseminate for use by private insurers. 
Government agencies would have the advantage of being mission-
driven to benefit the public but the disadvantage of being potentially 
captive to political interests.68 Political interests have already been a 
significant barrier, for example, to government initiatives in the 
Affordable Care Act (ACA) designed to promote comparative 
effectiveness research (CER), resulting in 
[m]any Republicans, private institutions, and conservative 
pundits [going] into “rhetorical overdrive,” with claims of 
government interference in patient care and rationing of 
services. Town hall meetings resonated with concerns over 
 
decision as to which specialty or specialties to include will depend on the particular procedure 
under study and the way clinical decisions are made in each country,” followed by a discussion of 
different approaches employed in the United States, Sweden, Spain, Switzerland, and the 
Netherlands. Fitch, supra note 29, at 23. 
 65. Patient-Centered Outcomes Research, PATIENT-CENTERED OUTCOMES RES. INST., 
http://www.pcori.org/research-we-support/pcor/ (last updated Nov. 7, 2013); see Our Study 
Process, INSTITUTE OF MEDICINE, http://www.iom.edu/About-IOM/Study-Process.aspx (last 
updated June 26, 2012). 
 66. See Containing Health Care Costs, THE MERCK MANUAL, http://www 
.merckmanuals.com/professional/special_subjects/financial_issues_in_health_care/containing 
_health_care_costs.html (last updated Oct. 2013) (stating that “[i]nsurance companies have 
limited access to care by denying coverage to people likely to need care”). 
 67. See Tanzina Vega, Insurers Seek to Soften Their Image, No Matter How Court Rules on 
Health Act, N.Y. TIMES, June 22, 2012, at A14 (quoting Harvard Business School professor 
Regina E. Herzlinger as stating that insurance providers “are among the most disliked industries 
in the United States”). 
 68. Ryan Abbott, Big Data and Pharmacovigilance: Using Health Information Exchanges to 
Revolutionize Drug Safety, 99 IOWA L. REV. 225, 257 (2013). 
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the creation of “death panels” and fear that the United 
States would adopt a “British-style” model of health care.69  
Efforts by government agencies to limit unnecessary care have also 
failed in the past. One of the highest profile historical examples 
occurred when the Agency for Health Care Policy and Research 
(AHCPR), which was created in 1989 to carry out outcomes studies, 
develop practice guidelines, and conduct and coordinate health 
services research, was criticized by the North American Spine 
Society (NASS) (an association of back surgeons), with the support 
of a number of Republican politicians, after the AHCPR reported 
that “there was no evidence to support spinal-fusion surgery and that 
such surgery commonly had complications.”70 The agency ultimately 
survived the incident, but with a new name that removed the word 
“policy”: the Agency for Healthcare Research and Quality 
(AHRQ).71 The incident also resulted in the abandonment of the 
agency’s practice guideline program and a 21 percent budget cut.72 
Regardless of what party develops Matrices of Appropriateness, 
private health insurance companies utilizing Matrices would gain a 
competitive advantage from being able to minimize spending on 
unnecessary care, which would provide a market-driven impetus to 
adopt a multi-level medical necessity rating system. As a general 
matter, medical necessity is defined in insurance contracts, and 
judicial interpretation of the language in policies is governed by the 
rules established for the construction and interpretation of written 
contracts generally.73 Some state laws specify a standard definition 
of medical necessity that health plans are required to use, but these 
states are in the minority.74 Other states have general legislation that 
might impact plans’ definitions of medical necessity75 even though 
there is no state-mandated definition, while yet a third set of states 
 
 69. Corinna Sorenson et al., The Politics of Comparative Effectiveness Research: Lessons 
from Recent History, 39.1 J. HEALTH POL. POL’Y & L. 139, 140 (2014) (internal citation omitted). 
 70. Id. at 147–48 (internal citation and quotation marks omitted). 
 71. Id. at 149. 
 72. Id. 
 73. 15 AM. JUR. 3D, supra note 20, § 355. 
 74. CENTER FOR HEALTH POLICY, STANFORD UNIVERSITY, STATE-BY-STATE COMPENDIUM 
OF MEDICAL NECESSITY REGULATION: SURVEY OF STATE MANAGED CARE REGULATORS 12 
(2001), available at http://www.hcfo.org/files/hcfo/stanford.pdf. (indicating that 11 states have 
any legislation that might impact plans’ definitions). 
 75. Id. 
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have no legislation that might impact a definition.76 While a  
state-by-state analysis is beyond the scope of this Article, insurers 
should be free to adopt a multi-level definition in most markets. The 
ACA does not define medical necessity.77 
The ACA does, however, significantly strengthen the external 
review process,78 and this represents an even stronger reason for 
insurers to adopt an unbiased, third-party Matrix of Appropriateness 
when making medical necessity determinations. The ACA 
establishes a set of rules for consumers to appeal a health insurance 
plan directly with the insurer (an internal appeal), as well as a right to 
have an independent review organization decide whether to uphold 
or overturn the plan’s decision (an external review).79 The 
conventional wisdom about external, or judicial, reviewers is that 
they tend to promote access to sympathetic patients.80 However, 
determinations adverse to insurers would probably be less likely 
when an insurer could demonstrate a medical necessity determination 
was made on the basis of an independently generated, non-biased, 
and evidence-based Matrix. The ACA also limits the upper bound of 
patient cost sharing; out-of-pocket limits for health plans are 
approximately $6,350 in 2014.81 
Unavoidably, variable co-pays for elective procedures would 
disproportionately affect low-income individuals, necessitating 
measures to balance the impact of co-pays according to each 
patient’s ability to pay them. This balancing could be accomplished 
through scaling co-pay amounts to a percentage of annual income. 
Extreme caution would be needed when applying this approach to 
potentially life-saving treatments for serious conditions such as 
cancer, despite the fact that the same basic principles govern medical 
 
 76. Id. 
 77. Daniel Skinner, Defining Medical Necessity under the Patient Protection and Affordable 
Care Act, 73 PUB. ADMIN. REV. S49, S50 (2013); see also Patient Protection and Affordable Care 
Act of 2010, Pub. L. No. 111-148, 124 Stat. 119 (2010) (codified at various sections) (failing to 
provide a definition for “medical necessity”). 
 78. See 42 U.S.C. § 300gg-19 (2014).  
 79. Id.; The Ctr. for Consumer Info. & Ins. Oversight, HHS-Administered Federal External 
Review Process for Health Insurance Coverage, CENTERS FOR MEDICARE AND MEDICAID 
SERVICES, http://www.cms.gov/CCIIO/Programs-and-Initiatives/Consumer-Support-and 
-Information/csg-ext-appeals-facts.html (last visited Jan. 26, 2014). 
 80. Sage, supra note 14, at 610–11. 
 81. Focus on Health Reform: Patient Cost-Sharing Under the Affordable Care Act, THE 
HENRY J. KAISER FAM. FOUND. 1, 3 (2012), http://kaiserfamilyfoundation.files.wordpress.com 
/2013/01/8303.pdf. 
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necessity determinations in these circumstances. For example, before 
high-dose chemotherapy followed by bone marrow transplant was 
proven not to extend the lives of patients suffering from metastatic 
breast cancer, many such procedures were performed. The 
procedures were, at the time, deemed medically necessary by virtue 
of the fact that practitioners were willing to undertake them and they 
held some hope on biological grounds of extending life or even 
curing the disease.82 Now, payers have stopped covering this costly 
and risky treatment for disseminated breast cancer because it does 
not meet current, dichotomous criteria for medical necessity, lacking 
proof of benefit after multiple clinical trials.83 
In many instances, however, similar clarity on the efficacy of 
emerging treatments for life-threatening conditions is not yet 
available, and it would be unethical to expose patients to high  
co-pays in circumstances where the science is not yet sufficiently 
clear to make a reasoned, balanced judgment of the relative risks and 
benefits of alternative approaches. However, the technique could be 
ethically applied to expand choice at the boundaries of current, 
dichotomous guidelines for managing potentially fatal illnesses. For 
example, the U.S. Preventive Services Task Force (USPSTF) 
recently recommended CT screening for lung cancer in heavy 
smokers between the ages of fifty-five and eighty.84 For patients with 
a strong preference for screening outside of these age and risk 
guidelines, variable co-pays could be offered to lower the cost of 
access to this potentially life-saving screening test, as long as a 
mechanism for balancing income disparities was in place. 
In conclusion, applying proven scientific methods to create 
detailed, multi-level ratings of medical necessity for the most 
commonly performed elective procedures, as well as for costly 
interventions with a variable likelihood of benefit, offers a strategy 
for reining in the overuse of diagnostic and therapeutic technologies. 
This strategy would improve the quality and value of medical care 
while maintaining an element of patient and consumer choice that 
balances preferences for alternative treatments with a willingness to 
 
 82. Sage, supra note 14, at 611. 
 83. Id. 
 84. Screening for Lung Cancer: U.S. Preventative Services Task Force Recommendation 
Statement, U.S. PREVENTIVE SERVICES TASK FORCE, http://www.uspreventiveservicestaskforce 
.org/uspstf13/lungcan/lungcanfinalrs.htm#summary (last updated Dec. 2013). 
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share in their costs. Because this strategy would be deployed in the 
insurance industry, which remains under the legal purview of each 
state, a variety of models could be tested. The principal challenges 
entailed by this approach include ensuring the objectivity and 
avoiding conflicts of interest in the development of the necessity 
ratings, and scaling co-pays to income to blunt a disproportionate 
impact on choice among lower-income individuals. Enshrined in the 
contracts that bind health plans and their members, as well as those 
between purchasers and health plans, variable co-pays for elective 
procedures based on objective, multi-level medical necessity ratings 
could offer a powerful tool for improving value while controlling 
costs. 
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